| Bioactivation of napabucasin triggers reactive oxygen species–mediated cancer cell death FEM Froeling, MM Swamynathan, A Deschênes, IIC Chio, E Brosnan, ... Clinical Cancer Research 25 (23), 7162-7174, 2019 | 69 | 2019 |
| The PHLPP2 phosphatase is a druggable driver of prostate cancer progression DG Nowak, KC Katsenelson, KE Watrud, M Chen, G Mathew, ... Journal of Cell Biology 218 (6), 1943-1957, 2019 | 43 | 2019 |
| LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells N Yokdang, J Hatakeyama, JH Wald, C Simion, JD Tellez, DZ Chang, ... Oncogene 35 (22), 2932-2947, 2016 | 43 | 2016 |
| FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer M M. Swamynathan, G Mathew, A Aziz, C Gordon, A Hillowe, H Wang, ... Cancers 16 (1), 60, 2023 | 3 | 2023 |
| Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function MM Swamynathan, S Kuang, KE Watrud, MR Doherty, C Gineste, ... Science 386 (6720), eadk9167, 2024 | 2 | 2024 |
| Internally controlled and dynamic optical measures of functional tumor biology T Chung, L Garcia, MM Swamynathan, FEM Froeling, LC Trotman, ... Analytical Chemistry 95 (13), 5661-5670, 2023 | 2 | 2023 |
| Abstract LB-021: LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of triple-negative/basal-B breast cancer cells N Yokdang, J Hatakeyama, J Wald, C Simion, J Tellez, D Chang, ... Cancer Research 76 (14_Supplement), LB-021-LB-021, 2016 | | 2016 |
| LRIG1 opposes epithelialto-mesenchymal transition and inhibits invasion of triple-negative/basal-B breast cancer cells N Yokdang, J Hatakeyama, J Wald, C Simion, J Tellez, D Chang, ... CANCER RESEARCH 76, 2016 | | 2016 |
